Tel Aviv University’s groundbreaking technology may
revolutionize the treatment of cancer and a wide range of diseases
and medical conditions. In the framework of this study, the
researchers were able to create a new method of transporting
RNA-based drugs to a subpopulation of immune cells involved in the
inflammation process, and target the disease-inflamed cell without
causing damage to other cells.